组织扩张器并发症后二次假体乳房重建仍可成功
BACKGROUND: Implant-based breast reconstruction is the most common method of breast reconstruction in the United States, but the outcomes of subsequent implant-based reconstruction after a tissue expander complication are rarely studied.…
要点
- 组织扩张器并发症后二次假体乳房重建长期成功率高。
- 二次尝试前无需因特定患者或手术因素排除假体重建。
- 应告知患者二次假体乳房重建是合理选择。
核心结论
- 组织扩张器并发症后,再次尝试组织扩张和假体置入是合理的,长期成功率高。
主要发现
- 二次置入者中34例(71%)无进一步并发症,38例(79%)最终假体乳房重建成功。
- 无患者或手术因素与二次并发症或假体丢失显著相关。
临床怎么用
- 组织扩张器并发症后,可向患者提供二次组织扩张和假体置入的选择。
- 无明确患者或手术因素可排除二次假体乳房重建尝试。
局限性
- 回顾性研究,证据等级为风险III级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Implant-based breast reconstruction is the most common method of breast reconstruction in the United States, but the outcomes of subsequent implant-based reconstruction after a tissue expander complication are rarely studied. The purpose of this study was to determine the long-term incidence of implant loss in patents with a previous tissue expander complication. METHODS: This is a retrospective review of the long-term outcomes of all patients with tissue expander complications at a large academic medical center from 2003 to 2013. Patients with subsequent tissue expander or implant complications were compared to those with no further complications to assess risk factors for additional complications or reconstructive failure. RESULTS: One hundred sixty-two women were included in this study. The mean follow-up period was 8.3 ± 3.1 years. Forty-eight women (30 percent) went on to undergo a second tissue expander or implant placement. They did not differ from women who went on to autologous reconstruction or no further reconstruction. Of these, 34 women (71 percent) had no further complications and 38 women (79 percent) had a successful implant-based reconstruction at final follow-up. There were no patient or surgical factors significantly associated with a second complication or implant loss. CONCLUSIONS: Following tissue expander complications, it is reasonable to offer women a second attempt at tissue expansion and implant placement. This study demonstrates that long-term success rates are high, and there are no definitive patient or surgical factors that preclude a second attempt at implant-based breast reconstruction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Poppler LH, Mundschenk MB, Linkugel A, et al. Tissue Expander Complications Do Not Preclude a Second Successful Implant-Based Breast Reconstruction. Plast Reconstr Surg. 2019. PMID: 30303927. doi:10.1097/PRS.0000000000005131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。